Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Particle Sciences, Inc. has expanded its development
capabilities to accommodate the increasing demand for biopharmaceutical formulation and
analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business
Development ...
read more
Monday, November 18, 2019
Lubrizol has announced that its CDMO, Particle Sciences, is to be renamed Lubrizol Life Science Health.
read more
Thursday, September 13, 2018
Particle Sciences has announced the appointment of Dr. Robert Lee to president.
read more
Wednesday, March 13, 2019
Particle Sciences has announced the appointment of Karen Bossert as vice president of operations as part of its ongoing strategy to grow and enhance its manufacturing capabilities.
read more
Monday, September 16, 2019
Particle Dynamics announced the completion of a new, state-of-the-art Product and Process Innovation Center located within its US-based, St Louis facilities.
read more
The bio-industry's most in-depth, global benchmarking and analysis study.
read more
Wednesday, August 20, 2025
The Parkinson's Foundation announced the launch of a new pilot program, PD Trial Navigator, which will help fulfill a central goal of the ongoing PD GENEration study to accelerate genetic-focused clinical trials. PD Trial Navigators will meet with ...
read more
Wednesday, August 12, 2015
Dr Nick Hutchinson from Parker domnick hunter, will be delivering a presentation at BioProduction 2015 about quality by design (QbD) and how it can be integrated into a bioprocess to ensure control over the post approval life cycle management plan.
read more
PAREXEL announced its ClinPhone RTSM, has been ranked as the leader of Interactive Response Technology, according to a global survey of pharmaceutical and biotechnology companies by Industry Standard Research.
read more
PAREXEL and Osaka International Cancer Institute announced that they have formed an alliance to advance clinical development in Japan.
read more
PAREXEL and Meiji Pharmaceutical University (MPU) announced a new Joint Program for Clinical Research and Clinical Trial Management for undergraduate students.
read more
Thursday, September 24, 2020
Parexel in collaboration with Innoplexus have launched the COVID-19 Clearinghouse, an online resource for patients, researchers and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials and current ...
read more
Parexel and HealthVerity have announced a strategic partnership to expand Parexel’s network of RWD sources to accelerate the delivery of drug development solutions for customers.
read more
Monday, September 17, 2018
PAREXEL and Datavant announced they are partnering to enhance clinical study design and operations, as well as the generation of real-world evidence.
read more
PAREXEL announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea.
read more